A biohazard bag, also known as a biohazardous or biomedical waste bag, is designed to contain and dispose of biohazardous wastes appropriately. These containers' red or orange marks indicate their purpose and possible danger. Biohazard containers are used in various settings, including medical institutions, research laboratories, and enterprises that work with potentially contagious materials. They are essential to biohazard waste management because they ensure the safe handling and disposal of infectious or possibly contaminated materials. The rapidly rising use of biohazard bags in diagnostic and lab testing samples and increased use in nursing homes, hospitals, and long-term care facilities is expected to boost the biohazard bag market share. As a result, the market has plenty of space to grow. Furthermore, with the rapidly developing global e-commerce sales channel, the availability of biohazard bags has increased.
Healthcare waste growth drives the worldwide biohazard bag market. Biohazard bags are needed when medical facilities handle more contagious and hazardous goods. Hospital waste control is crucial during the COVID-19 pandemic. Healthcare, testing, and quarantine facilities generate infectious waste from used PPE, infected medical supplies, and disposables. These things must be disposed of safely to prevent infections among healthcare staff, patients, and the public. According to the WHO, COVID-19 has increased healthcare waste, especially in hospitals. Some countries saw medical waste climb from 200% to 300% during the outbreak. Proper waste treatment and disposal were prioritized to reduce disease transmission.
However, some sectors and healthcare institutions may lack biohazard bag awareness and training. Thus, inappropriate handling and disposal may increase infection risk and environmental risks. In a survey of medical staff, the Journal of Occupational and Environmental Medicine revealed that many were unaware of biohazard waste management. Many respondents were unaware of how to properly identify and dispose of medical waste, particularly biohazardous materials, inhibiting biohazard bag business growth.
The growing patient population, especially in infectious disease outbreaks, suggests the biohazard bag market could increase to satisfy the need for safe and effective medical waste management solutions. Healthcare institutions, waste management companies, and biohazard bag producers can use this opportunity to collaborate and develop new solutions for different healthcare situations. High-quality, compliant biohazard bags can safeguard healthcare workers, prevent infection, and protect the environment. The WHO reported over a certain number of confirmed COVID-19 cases worldwide as of a certain date. Due to the high number of cases, medical waste, particularly biohazardous waste, has increased, putting strain on healthcare systems to manage waste. Public health campaigns emphasizing proper waste disposal during outbreaks may also boost biohazard bag sales. Waste management and biohazard bags in hospitals also enhance the market.
North America is likely to dominate the biohazard bag market. As infectious diseases increase, so will demand for sophisticated surgical and medical technologies, resulting in waste and residues. This area's massive biohazard waste will increase biohazard bag demand. Healthcare spending and infrastructure are also driving regional market growth. The US leads the biohazard bag sector because of its high cancer rate. The American Cancer Society's Cancer Statistics 2022 predicts 1,918,030 new cancer cases in 2022. Chemotherapy and radiation can harm patients, workers, and visitors. Radioisotopes used in therapies and diagnostics can trigger mutations if not protected. Thus, the country's high cancer rate will likely boost biohazard bag market growth throughout the estimate.
Asia Pacific maintained a high market share in 2022 due to many hospital beds, a growing patient population, and many biohazard bag suppliers. India and China have 8 million hospital beds. The WHO recommends five hospital beds per 1000 people. Biohazard bags may be in demand due to hospital investment and waste management awareness. Biohazard bags are in demand due to investment and medical waste reduction. The government is considering biomedical or biohazardous waste market growth reduction measures. In August 2022, the Government of Japan and the UNDP launched a new project to help national health agencies and other key stakeholders in Bangladesh, Bhutan, and the Maldives address the unprecedented rise in infectious healthcare waste caused by the COVID-19 pandemic, which is overwhelming waste treatment facilities. The USD 11 million two-year infectious waste control program will boost market development.
The Middle East and Africa are expected to grow rapidly. The huge populations of these continents could raise biohazard bag demand as trash production rises. According to Saudi Arabia's Health Indicators 2021 report, there were 13.6 million emergency department visits, 0.5 million surgical operations, 232,216 births, and 186 million lab exams in 2021. Thus, the substantial medical intervention patient pool will drive sector expansion during the projected timeframe. Healthcare organizations and ministries invest more in hospital sterility, disinfection, and waste management due to various dangerous diseases.
The key players in the global Biohazard bag market are Stericycle, Merck KGaA, Heathrow Scientific., Thomas Scientific, Daniels Sharpsmart Inc., SP Bel-Art, Transcendia, and VWR International, LLC. , BioMedical Waste Solutions, LLC, Clean Harbors, Inc., Daniels Sharpsmart, Inc., Thermo Fisher Scientific, Merck KGaA, Bel-Art SP Scienceware, TufPak, Dynalon, International Plastics Inc, Desco Medical, Cole-Parmer, and Minigrip LLC.